Healthcare Costs and Resource Utilization Associated with the Use of Empagliflozin Versus Other Antihyperglycemic Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Real-World Retrospective Cohort Analysis
Crossref DOI link: https://doi.org/10.1007/s13300-021-01173-0
Published Online: 2021-11-02
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Raju, Aditya http://orcid.org/0000-0003-2223-1865
Pimple, Pratik
Stafkey-Mailey, Dana
Farrelly, Eileen
Shetty, Sharash
Text and Data Mining valid from 2021-11-02
Version of Record valid from 2021-11-02
Article History
Received: 26 August 2021
Accepted: 8 October 2021
First Online: 2 November 2021